Drugs / 627
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07065136 | Jul 2025 → Sep 2026 overdue | — | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 627 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07065136 ↗ |
| Route | Subcutaneous | “single subcutaneous injection” NCT07065136 ↗ |